找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Biological Mechanisms of Minimal Residual Disease and Systemic Cancer; Julio A.‘Aguirre-Ghiso Book 2018 Springer Nature Switzerland AG 201

[复制链接]
楼主: finesse
发表于 2025-3-23 12:29:07 | 显示全部楼层
https://doi.org/10.1007/978-3-658-18524-4uantitatively assess residual disease and accurately prognosticate PFS and OS in myeloma. In this chapter, we will discuss the current techniques for MRD detection as well as describe techniques that are emerging for improved characterization of drug resistant residual populations that could be adap
发表于 2025-3-23 17:00:42 | 显示全部楼层
0065-2598 .   .. ..This book is edited and prefaced by Dr. Julio Aguirre-Ghiso, an expert in dormancy and recurrence. The chapters are written by world-recognized experts Drs. Ravi Bahtia, Samir Parekh, Russel Taichman, 978-3-319-97746-1Series ISSN 0065-2598 Series E-ISSN 2214-8019
发表于 2025-3-23 18:34:43 | 显示全部楼层
发表于 2025-3-23 23:32:43 | 显示全部楼层
Biological Mechanisms of Minimal Residual Disease and Systemic Cancer
发表于 2025-3-24 04:28:14 | 显示全部楼层
Preservation of Quiescent Chronic Myelogenous Leukemia Stem Cells by the Bone Marrow Microenvironmelated to tyrosine kinase independent mechanisms which include intrinsic properties of LSCs determined by epigenetic alterations, altered transcriptional regulatory networks or mitochondrial/metabolic changes. In addition to cell intrinsic changes, signals from the bone marrow microenvironment (BMM)
发表于 2025-3-24 06:38:24 | 显示全部楼层
Minimal Residual Disease in Multiple Myeloma: Impact on Response Assessment, Prognosis and Tumor Heuantitatively assess residual disease and accurately prognosticate PFS and OS in myeloma. In this chapter, we will discuss the current techniques for MRD detection as well as describe techniques that are emerging for improved characterization of drug resistant residual populations that could be adap
发表于 2025-3-24 12:11:08 | 显示全部楼层
Auf das Nerven system wirken de Stoffe,ion, anti-angiogenic agents were expected to suppress the growth of any type of primary or metastatic tumor, independent of their subtype or genetic landscape. However, more that 20 years after the first anti-angiogenic preclinical trial, the astonishing inhibition of metastatic outgrowth originally
发表于 2025-3-24 15:49:30 | 显示全部楼层
发表于 2025-3-24 19:43:11 | 显示全部楼层
发表于 2025-3-25 01:32:32 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-6-26 07:19
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表